The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC: A Clinical Trial by the Danish Lung Cancer Group

Ditte Sloth Møller, Jon L Andersen, Ane L Appelt, Carsten Brink, Olfred Hansen, Lone Hoffmann, Nikolaj K G Jensen, Mirjana Josipovic, Azza Ahmed Khalil, Marianne Marquard Knap, Mikkel D Lund, Christina Maria Lutz, Martin Skovmos Nielsen, Svetlana Kunwald Nielsen, Tine B Nielsen, Christina H Nyhus, Wiviann Ottoson, Gitte F Persson, Patrik Sibolt, Kim WedervangTine Schytte

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

11 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftJournal of Thoracic Oncology
Vol/bind10
Udgave nummer9, Suppl. 2
Sider (fra-til)S286-5287
ISSN1556-0864
DOI
StatusUdgivet - 2015
BegivenhedThe World Conference on Lung Cancer - Denver, Colorado, USA, Denver, USA
Varighed: 6 sep. 20159 sep. 2015
Konferencens nummer: 16th

Konference

KonferenceThe World Conference on Lung Cancer
Nummer16th
LokationDenver, Colorado, USA
LandUSA
ByDenver
Periode06/09/201509/09/2015

Citer dette

Sloth Møller, D., Andersen, J. L., Appelt, A. L., Brink, C., Hansen, O., Hoffmann, L., ... Schytte, T. (2015). The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC: A Clinical Trial by the Danish Lung Cancer Group. Journal of Thoracic Oncology, 10(9, Suppl. 2), S286-5287. https://doi.org/10.1016/S1556-0864(16)30011-9
Sloth Møller, Ditte ; Andersen, Jon L ; Appelt, Ane L ; Brink, Carsten ; Hansen, Olfred ; Hoffmann, Lone ; Jensen, Nikolaj K G ; Josipovic, Mirjana ; Khalil, Azza Ahmed ; Marquard Knap, Marianne ; Lund, Mikkel D ; Lutz, Christina Maria ; Nielsen, Martin Skovmos ; Kunwald Nielsen, Svetlana ; Nielsen, Tine B ; Nyhus, Christina H ; Ottoson, Wiviann ; Persson, Gitte F ; Sibolt, Patrik ; Wedervang, Kim ; Schytte, Tine. / The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC : A Clinical Trial by the Danish Lung Cancer Group. I: Journal of Thoracic Oncology. 2015 ; Bind 10, Nr. 9, Suppl. 2. s. S286-5287.
@article{9e4633599f8c4c908ad9512cfd968f2b,
title = "The NARAL{"} Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC: A Clinical Trial by the Danish Lung Cancer Group",
author = "{Sloth M{\o}ller}, Ditte and Andersen, {Jon L} and Appelt, {Ane L} and Carsten Brink and Olfred Hansen and Lone Hoffmann and Jensen, {Nikolaj K G} and Mirjana Josipovic and Khalil, {Azza Ahmed} and {Marquard Knap}, Marianne and Lund, {Mikkel D} and Lutz, {Christina Maria} and Nielsen, {Martin Skovmos} and {Kunwald Nielsen}, Svetlana and Nielsen, {Tine B} and Nyhus, {Christina H} and Wiviann Ottoson and Persson, {Gitte F} and Patrik Sibolt and Kim Wedervang and Tine Schytte",
year = "2015",
doi = "10.1016/S1556-0864(16)30011-9",
language = "English",
volume = "10",
pages = "S286--5287",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier",
number = "9, Suppl. 2",

}

Sloth Møller, D, Andersen, JL, Appelt, AL, Brink, C, Hansen, O, Hoffmann, L, Jensen, NKG, Josipovic, M, Khalil, AA, Marquard Knap, M, Lund, MD, Lutz, CM, Nielsen, MS, Kunwald Nielsen, S, Nielsen, TB, Nyhus, CH, Ottoson, W, Persson, GF, Sibolt, P, Wedervang, K & Schytte, T 2015, 'The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC: A Clinical Trial by the Danish Lung Cancer Group', Journal of Thoracic Oncology, bind 10, nr. 9, Suppl. 2, s. S286-5287. https://doi.org/10.1016/S1556-0864(16)30011-9

The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC : A Clinical Trial by the Danish Lung Cancer Group. / Sloth Møller, Ditte; Andersen, Jon L; Appelt, Ane L; Brink, Carsten; Hansen, Olfred; Hoffmann, Lone; Jensen, Nikolaj K G; Josipovic, Mirjana; Khalil, Azza Ahmed; Marquard Knap, Marianne; Lund, Mikkel D; Lutz, Christina Maria; Nielsen, Martin Skovmos; Kunwald Nielsen, Svetlana; Nielsen, Tine B; Nyhus, Christina H; Ottoson, Wiviann; Persson, Gitte F; Sibolt, Patrik; Wedervang, Kim; Schytte, Tine.

I: Journal of Thoracic Oncology, Bind 10, Nr. 9, Suppl. 2, 2015, s. S286-5287.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC

T2 - A Clinical Trial by the Danish Lung Cancer Group

AU - Sloth Møller, Ditte

AU - Andersen, Jon L

AU - Appelt, Ane L

AU - Brink, Carsten

AU - Hansen, Olfred

AU - Hoffmann, Lone

AU - Jensen, Nikolaj K G

AU - Josipovic, Mirjana

AU - Khalil, Azza Ahmed

AU - Marquard Knap, Marianne

AU - Lund, Mikkel D

AU - Lutz, Christina Maria

AU - Nielsen, Martin Skovmos

AU - Kunwald Nielsen, Svetlana

AU - Nielsen, Tine B

AU - Nyhus, Christina H

AU - Ottoson, Wiviann

AU - Persson, Gitte F

AU - Sibolt, Patrik

AU - Wedervang, Kim

AU - Schytte, Tine

PY - 2015

Y1 - 2015

U2 - 10.1016/S1556-0864(16)30011-9

DO - 10.1016/S1556-0864(16)30011-9

M3 - Conference abstract in journal

VL - 10

SP - S286-5287

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 9, Suppl. 2

ER -